
USA - NYSE:CNVY - US21258C1080 - Common Stock
ChartMill assigns a Buy % Consensus number of 49% to CNVY. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-06-22 | Guggenheim | Downgrade | Buy -> Neutral |
| 2022-06-22 | Barclays | Downgrade | Overweight -> Equal-Weight |
| 2022-05-12 | Goldman Sachs | Maintains | Neutral |
| 2021-07-12 | Barclays | Initiate | Overweight |
| 2021-07-12 | Truist Securities | Initiate | Buy |
| 2021-07-12 | JP Morgan | Initiate | Neutral |
| 2021-07-12 | Canaccord Genuity | Initiate | Buy |
| 2021-07-12 | B of A Securities | Initiate | Buy |
9 analysts have analysed CNVY and the average price target is 11.22 USD. This implies a price increase of 6.76% is expected in the next year compared to the current price of 10.51.
The consensus rating for Convey Health Solutions Holdings Inc (CNVY) is 48.8889 / 100 . This indicates that analysts generally have a neutral outlook on the stock.